Stock Market & Financial Investment News

News Breaks September 21, 2012 12:00 EDT BMY, PFE Bristol-Myers and Pfizer receive positive opinion on Eliquis Bristol-Myers Squibb (BMY) and Pfizer (PFE) announced that the Committee for Medicinal Products for Human Use, or CHMP, of the European Medicines Agency, or EMA, has adopted a positive opinion recommending that Eliquis be granted approval for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation and one or more risk factors for stroke. The CHMP's positive opinion will now be reviewed by the European Commission, which has the authority to approve medicines for the European Union. The final decision will be applicable to all 27 European Union member states plus Iceland and Norway. News For BMY;PFE From The Last 14 Days Check below for free stories on BMY;PFE the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. 1 | 2 | all recent news | >> May 23, 2013 06:02 EDT BMY Bristol-Myers implied volatility at upper end of index mean range 05:47 EDT BMY Stocks with implied volatility movement; SKS BMY Stocks with implied volatility movement; Saks (SKS), Bristol-Myers (BMY) according to IVolatility. May 22, 2013 16:00 EDT BMY Options Update; May 22, 2013 Subscribe for More Information 10:33 EDT BMY Bristol-Myers jumps after Citi ups rating on cancer potential Subscribe for More Information 10:16 EDT BMY Bristol-Myers spikes higher following upgrade, levels to watch Subscribe for More Information 10:00 EDT BMY On The Fly: Analyst Upgrade Summary Subscribe for More Information 08:59 EDT PFE On The Fly: Pre-market Movers Subscribe for More Information 08:06 EDT PFE Zoetis comments on Pfizer’s split-off plans for remaining interest Subscribe for More Information 08:04 EDT PFE Pfizer announces plan to split-off remainder of Zoetis Subscribe for More Information 08:02 EDT PFE Pfizer announces plan to split-off remainder of Zoetis Subscribe for More Information 06:05 EDT BMY Bristol-Myers upgraded to Buy from Neutral at Citigroup Subscribe for More Information May 21, 2013 07:34 EDT BMY UBS to host a conference Subscribe for More Information 07:24 EDT BMY Global Health Care to host a conference Subscribe for More Information 07:16 EDT PFE Pfizer management to meet with Leerink Subscribe for More Information May 20, 2013 17:04 EDT PFE Pfizer discontinues phase 3 study of inotuzumab ozogamicin Subscribe for More Information 10:03 EDT BMY Shire advances after report renews takeover speculation Subscribe for More Information 06:30 EDT BMY Leerink estimates Shire takeout value at least $110 per share Leerink says a takeover price for Shire (SHPG) would need to be at least $110 per share in order to get the company's board to consider a sale. The firm notes a Daily Mail report last night said Bristol-Myers (BMY) has engaged advisors to study an acquisition of Shire and that Shire's CEO has contacted bankers to consider anti-takeover measures. Leerink believes a Bristol-Myers takeover of Shire would make sense and keeps an Outperform rating on Shire. 06:25 EDT BMY Shire may return cash to thwart takeover, Daily Mail reports Subscribe for More Information May 17, 2013 13:21 EDT BMY Options with increasing implied volatility: CPRT BMY GDI HNZ Subscribe for More Information May 16, 2013 16:32 EDT BMY Bristol-Myers announces intention to voluntarily delist preferred stock Subscribe for More Information 1 | 2 | all recent news | >> Sign up for a free trial to see the rest of the stories you've been missing.